title: NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.
abstract: Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA 02115, USA. Matthew_kulke@dfci.harvard.edu
authors.forename: Matthew H
authors.initials: MH
authors.lastname: Kulke
authors.forename: Lowell B
authors.initials: LB
authors.lastname: Anthony
authors.forename: David L
authors.initials: DL
authors.lastname: Bushnell
authors.forename: Wouter W
authors.initials: WW
authors.lastname: de Herder
authors.forename: Stanley J
authors.initials: SJ
authors.lastname: Goldsmith
authors.forename: David S
authors.initials: DS
authors.lastname: Klimstra
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Marx
authors.forename: Janice L
authors.initials: JL
authors.lastname: Pasieka
authors.forename: Rodney F
authors.initials: RF
authors.lastname: Pommier
authors.forename: James C
authors.initials: JC
authors.lastname: Yao
authors.forename: Robert T
authors.initials: RT
authors.lastname: Jensen
mesh_terms: D005770:Gastrointestinal Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D018358:Neuroendocrine Tumors / Q000473:pathology / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000628:therapy*